Moderna
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
CEOStéphane Bancel
CEOStéphane Bancel
Employees5,800
Employees5,800
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees5,800
Employees5,800
MRNA Key Statistics
Market cap10.63B
Market cap10.63B
Price-Earnings ratio-3.64
Price-Earnings ratio-3.64
Dividend yield—
Dividend yield—
Average volume9.63M
Average volume9.63M
High today$27.34
High today$27.34
Low today$27.32
Low today$27.32
Open price$27.58
Open price$27.58
Volume42.24K
Volume42.24K
52 Week high$59.73
52 Week high$59.73
52 Week low$23.15
52 Week low$23.15
MRNA News
Simply Wall St 3d
Moderna: Evaluating Valuation Prospects as Shares Show Renewed MomentumModerna (MRNA) shares edged higher today, building on recent momentum in the stock. Some investors are taking a closer look at the biotech’s underlying fundamen...
Nasdaq 6d
November 14th Options Now Available For ModernaInvestors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the November 14th expiration. At Stock Options Channel , our YieldBoost formula...
Analyst ratings
59%
of 27 ratingsBuy
22.2%
Hold
59.3%
Sell
18.5%
People also own
Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.